ESTABLISHMENT LABS HLDGS
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force… Read more
Market Cap & Net Worth: ESTABLISHMENT LABS HLDGS (3E0)
ESTABLISHMENT LABS HLDGS (F:3E0) has a market capitalization of $1.66 Billion (€1.61 Billion) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #7029 globally and #745 in its home market, demonstrating a -8.26% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ESTABLISHMENT LABS HLDGS's stock price €55.50 by its total outstanding shares 29057868 (29.06 Million).
ESTABLISHMENT LABS HLDGS Market Cap History: 2018 to 2026
ESTABLISHMENT LABS HLDGS's market capitalization history from 2018 to 2026. Data shows growth from $600.72 Million to $1.66 Billion (13.33% CAGR).
ESTABLISHMENT LABS HLDGS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ESTABLISHMENT LABS HLDGS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 3E0 by Market Capitalization
Companies near ESTABLISHMENT LABS HLDGS in the global market cap rankings as of March 19, 2026.
Key companies related to ESTABLISHMENT LABS HLDGS by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
ESTABLISHMENT LABS HLDGS Historical Marketcap From 2018 to 2026
Between 2018 and today, ESTABLISHMENT LABS HLDGS's market cap moved from $600.72 Million to $ 1.66 Billion, with a yearly change of 13.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.66 Billion | -7.50% |
| 2025 | €1.79 Billion | +63.93% |
| 2024 | €1.09 Billion | +21.19% |
| 2023 | €900.78 Million | -48.38% |
| 2022 | €1.74 Billion | +10.38% |
| 2021 | €1.58 Billion | +93.43% |
| 2020 | €817.26 Million | +18.10% |
| 2019 | €691.99 Million | +15.19% |
| 2018 | €600.72 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ESTABLISHMENT LABS HLDGS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.66 Billion USD |
| MoneyControl | $1.66 Billion USD |
| MarketWatch | $1.66 Billion USD |
| marketcap.company | $1.66 Billion USD |
| Reuters | $1.66 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.